Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar-Reference-Cited by-同舟云学术

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Published:2021-12-09 Issue:24 Volume:385 Page:e83
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Chemaitelly Hiam¹,Tang Patrick¹^ORCID,Hasan Mohammad R.¹,AlMukdad Sawsan¹,Yassine Hadi M.¹,Benslimane Fatiha M.¹,Al Khatib Hebah A.¹,Coyle Peter¹,Ayoub Houssein H.¹^ORCID,Al Kanaani Zaina¹,Al Kuwari Einas¹,Jeremijenko Andrew¹,Kaleeckal Anvar H.¹,Latif Ali N.¹,Shaik Riyazuddin M.¹,Abdul Rahim Hanan F.¹,Nasrallah Gheyath K.¹,Al Kuwari Mohamed G.¹,Al Romaihi Hamad E.¹,Butt Adeel A.¹^ORCID,Al-Thani Mohamed H.¹,Al Khal Abdullatif¹,Bertollini Roberto¹,Abu-Raddad Laith J.¹^ORCID

Affiliation:

1. From the Infectious Disease Epidemiology Group (H.C., S.A., L.J.A.-R.) and the World Health Organization Collaborating Center for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis (H.C., S.A., L.J.A.-R.), Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation–Education City, the Department of Pathology, Sidra Medicine (P.T., M.R.H.), the Biomedical Research Center, Member of QU Health (H.M.Y., F.M.B., H.A.A.K., P.C., G.K.N.), the Departments of...

Funder

Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine–Qatar

Ministry of Public Health, Hamad Medical Corporation, and the Qatar Genome Programme

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2114114

Cited by 714 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 infection prevalence, risk factors, and outcomes among non-clinical-related service providers in a national healthcare system;Global Epidemiology;2024-12

2. Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting;Vaccine;2024-10

3. In vitro study on efficacy of SKF7®, a Malaysian medicinal plant product against SARS-CoV-2;BMC Complementary Medicine and Therapies;2024-09-11

4. Trust Us—We Are the (COVID-19 Misinformation) Experts: A Critical Scoping Review of Expert Meanings of “Misinformation” in the Covid Era;COVID;2024-09-10

5. Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection;Antibodies;2024-09-02